Back to VA Vanguard Capital Management LLC
EIKN
2 quarters
Position history for VAVanguard Capital Management LLC's holdings in Eikon Therapeutics, Inc.
Yes. Vanguard Capital Management holds 922,707 shares of EIKN (Eikon Therapeutics), worth $12M, as of its Q2 2026 13F filing. It reduced the position by 46,724 shares (-4.8%) from Q1 2026. Vanguard Capital Management has held EIKN in every 13F on record since Q1 2026, 2 quarterly filings.
Current Value
$12M
Current Shares
922,707
Total Value Change
+$1.8M
Total Shares Change
-46,724
Quarter-by-Quarter History
Other major holders of EIKN: FMR LLC, BlackRock, Inc., Capital World Investors